Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(4-((2r)-2-aminopropoxy)phenyl)-n-((1r)-1-(3-fluorophenyl)ethyl)imidazo(1,2-b)pyridazin-6-amine;hexanedioic Acid
1. Ds-6051b
2. 1505515-69-4
3. Taletrectinib Adipate
4. Ds-6051b Adipate
5. 6kll51gnbg
6. Taletrectinib Adipate [usan]
7. 1505515-69-4 (adipate)
8. 3-(4-((r)-2-aminopropoxy)phenyl)-n-((r)-1-(3-fluorophenyl)ethyl)imidazo[1,2-b]pyridazin-6-amine Adipate
9. 3-[4-[((2r)-2-aminopropyl)oxy]phenyl]-n-[(1r)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine Monoadipate
10. 3-[4-[(2r)-2-aminopropoxy]phenyl]-n-[(1r)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine;hexanedioic Acid
11. Unii-6kll51gnbg
12. Ab-106 Adipate
13. Chembl4650361
14. Schembl16468541
15. Glxc-25968
16. Ex-a4255
17. S8901
18. Ac-36532
19. Hy-131003
20. Cs-0120270
21. F78020
22. 3-(4-((r)-2-aminopropoxy)phenyl)-n-((r)-1-(3-fluorophenyl)ethyl)imidazo[1,2-b]pyridazin-6-amine (1:1)
23. 8-trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine
24. Hexanedioic Acid, Compd. With 3-[4-[(2r)-2-aminopropoxy]phenyl]-n-[(1r)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine (1:1)
| Molecular Weight | 551.6 g/mol |
|---|---|
| Molecular Formula | C29H34FN5O5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 12 |
| Exact Mass | 551.25439736 g/mol |
| Monoisotopic Mass | 551.25439736 g/mol |
| Topological Polar Surface Area | 152 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Taletrectinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taletrectinib, including repackagers and relabelers. The FDA regulates Taletrectinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taletrectinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Taletrectinib supplier is an individual or a company that provides Taletrectinib active pharmaceutical ingredient (API) or Taletrectinib finished formulations upon request. The Taletrectinib suppliers may include Taletrectinib API manufacturers, exporters, distributors and traders.
Taletrectinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Taletrectinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Taletrectinib GMP manufacturer or Taletrectinib GMP API supplier for your needs.
A Taletrectinib CoA (Certificate of Analysis) is a formal document that attests to Taletrectinib's compliance with Taletrectinib specifications and serves as a tool for batch-level quality control.
Taletrectinib CoA mostly includes findings from lab analyses of a specific batch. For each Taletrectinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Taletrectinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Taletrectinib EP), Taletrectinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Taletrectinib USP).
LOOKING FOR A SUPPLIER?
